AzTrials
AzTrials

Dental ExtractionNCT06915675

Human Placenta Extract Use in Socket Preservation

A study testing Placental Extract and Allograft in people with Dental Extraction, run by Saint-Joseph University at 1 site in Lebanon.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This split-mouth pilot study evaluates the effectiveness of flowable decellularized Human Placental Connective Tissue Matrix (HPCTM) in alveolar ridge preservation following tooth extraction. Read more about this study

Who is it for?
Ages 20 to 60 years
Conditions the study is for
Dental Extraction
What is being tested?
Placental Extract and Allograft
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
10 participants
Where
1 siteLebanon
Study dates
23 Aug 2024to 10 Apr 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Age ranging between 20 and 60.
  • Subjects having two hopeless teeth that needs extraction.
  • Teeth fitting in the same morphological category (mono,bi or multirooted).
  • Teeth belonging to different arch quadrants.
  • Presence of more than half of the socket bone housing.
  • Non-smoking patient.

Who cannot join

  • Presence of active periodontal diseases i.e Miller class II and above categories.
  • Presence of heavy metallic artefacts that can distort CBCT scans.
  • Bad oral hygiene and non-compliance.
  • Systemic diseases interfering with bone metabolism.
  • Pregnant or lactating women.

Trial locations and contacts

1 site in 1 country.

Lebanon1 site
  • Saint Joseph University of Beirut

    Beirut, Beirut, 1101

Other trials in Lebanon

About this study

Official title: The Adjunction of Flowable Decellularized Human Placental Connective Tissue Matrix in Alveolar Ridge Preservation: A Split Mouth Pilot Study

This split-mouth pilot study evaluates the effectiveness of flowable decellularized Human Placental Connective Tissue Matrix (HPCTM) in alveolar ridge preservation following tooth extraction. Patients will receive HPCTM mixed with allograft particles in one extraction socket and allograft particles solely in the contralateral socket. The primary outcome is to assess dimensional changes in the alveolar ridge in terms of soft tissue shrinkage using a super-imposed intra-oral scans taken at baseline , day 10, 21 and 30 post-op and bone resorption rate by comparing pre-op and 4 months post-op cone beam computed tomography scans. Secondary outcomes include clinical soft tissue healing evaluation and commentary. The HPCTM used in this study is regulated by the US FDA under Section 361 of the Public Health Service Act (21 CFR Part 1271.10(a)).

Read the detailed description
  • Data collection: The data collection process of the patients was divided into two steps: pre and post Alvealoar ridge preservation.

Before the surgery, clinical photographs using a digital single-lens reflex camera (Canon 90D, 100mm macro lens, Tokyo, Japan) equipped with a light diffuser (Flashkap, USA), CBCT and intra-oral scans of each patient were collected and stored separately.

After the surgery, the patients were asked to re-visit the dental clinic at 10,21 and 30 days post-operatively for a check-up, clinical photographs and intra-oral scans. Following a period of 4 months, the patients were again recalled to perform a CBCT scan and get sufficient information about the implant placement.

Surgical intervention:

All cases were performed by the same surgeon (B.H) who followed the same surgical protocol.

Following local anesthesia and crown removal if present (Fig. 1A,B) a minimally invasive cut using fissure carbide burrs (FG701, Neoburr, Republic of Korea) was performed to separate the mesial and distal roots. Subsequently the roots were luxated and extracted using elevators (EL3S, Hu-Friedy, USA) (Figure 1B, C). The alveolar sockets were debrided using Lucas curettes. Since avoiding blood inundation of the bone chips is not possible and to dodge any methodology biais, allografts were mixed with blood in both sites. The test sites received 0,5 cc of HCTM (Orafyl, Biocellgraft, USA) regulated by the US Food and Drug Administration (FDA) under Section 361 of the Public Health Service (HCT/P, 21 CFR, Part 1271.10(a) mixed with 0,5 cc of the patient's blood, the mixing procedure involved the use of a double syringes model with a mixing time of 2 minutes (Figure 2A). 1 cc of allografts particles (Maxgraft Cortico cancellous granules, Botiss, Germany) were mixed with the prepared serum continuously till a moldable putty was formed (Figure 2B). Subsequently, the bone putty was grafted in the socket and compacted softly till reaching the radiographic coronal limit of the socket (Figure 1F). Due to compaction process the excess of blood mixed with the gel filled the gingival portion of the socket resulting in a thick gelatinous seal of the socket. X shaped 5/0 Polytetrafluoroethylene sutures (Biotex, Purgo biologics, Republic of Korea) sutures were performed on the top of the socket to secure the grafted particles from spilling, care was giving to not displace the gingival margins of the socket (Figure 1H). The control socket received the same therapeutical treatment but with blood solely mixed to the allografts (Figure 1E) and a collagen fleece on top to prevent the bone particles from displacement (Figure 1G As a post-operative recommendation, the patients were advised to abstain from any gargling or spitting for 24 hours. The patients were given antibiotics for 7 days 2 g/day orally (Amoxicillin Sandoz®, Basel, Switzerland). Non-steroidal ani inflammatory drug ibuprofen 400 mg (Abbott Laboratories, Chicago, USA) three times daily for 3 days, and a chlorhexidine mouthwash (0.12%), three times daily for 2 weeks.

4 months post-op, a CBCT scan was performed to assess the bone dimensions and patients were recalled for implants placement. A full thickness flap was raised (Figure 3A) and implants (Blue diamond, Mega'gen, Republic of Korea) were placed in a prosthetically driven fashion making sure that the fixture was surrounded by at least 2 mm of bone buccally and lingually. Anatomical healing caps were used in order to sculpt an ideal prosthetic emergence profile (Figure 3B). Finally, two months later, a digital impression of the placed implant was performed using an intra-oral scan (R2I3, Mega'gen, Republic of Korea) and screw retained Zirconia crowns were delivered for each patient (Figure 3C, D).

-Studied parameters identification:

The studied parameters in this study were as follow:

  1. Volumetric bone resorption rate expressed in %
  2. Linear soft tissue shrinkage expressed in millimeters.
  3. Clinical observation and interpretation of wound healing in test and control groups

2.5 Soft tissue healing measurements:

For an accurate and clear measurements several steps were followed; First all intra-oral scans were exported as a stereolithography file (STL). The initial intra-oral scans were imported to an imaging software and aligned to the CBCT scan using multiple stable landmarks, this scan was set as a reference, then they were exported to a design software (Medit Design, Medit, Republic of Korea) where teeth in relation were extracted virtually and the sockets filled till the top of the free gingiva. The follow-up intra-oral scans were imported to the same software and super-imposed using a semi-automatic option with up to 5 points were used as a stable reference. The region of interest was delimited using the trimming option as follow:

  • Mesio-distally: 1,5 mm away from the concerned papilla peak.
  • Apically: A bucco-lingual/palatal line tangent to the visible muco-gingival line and parallel to the occlusal surface.

Using the deviation analysis option of the software, a color map quantifying any positive or negative deviations between the different time points scans in comparison to the baseline was generated (Fig. 4).

2.6 Bone resorption measurements:

The hard tissue resorption measurement technique in a previous article published by the same authors was adopted 17. A semi-automatic segmentation software (ITK-Snap 4.0, U.S. National Institute of Biomedical Imaging and BioEngineering, USA) was used to load and segment the pre and post CBCT scans. First, both CBCTs were oriented according to the Frankfort plane, then aligned using multiple fixe landmarks in different orientations to ensure a perfect match and an easy reproducibility. A standard region of interest was applied for all the measured sites as follow:

A standard region of interest was applied for all the measured sites as follow:

  • Mesio-distal limit: 1.5 mm away from the mesial and distal surface of adjacent tooth.
  • Bucco-lingual limit: limited to the observed bone dimensions.
  • Apico-coronal limit: Coronally the most detectable bone peak at the mesial and distal sides; apically, 1.5 mm below the root tip.

Using pixel-based scale, a specific threshold value was used to select and separate the desired structure from its surroundings of both pre and post-surgery CBCT. Following the automatic segmentations, a manual inspection was applied to eliminate any undesired selections and the volume of each created shape was measured using the software built-in tools (Fig. 5).

The resorption rate was calculated following the mathematical equation:

[ ( VPre-op-Vpost-op) / VPre-op] X 100.

Statistical analysis:

A descriptive statistical analysis was performed to describe the patient's characteristics. The data was expressed as the mean ± standard deviation. The Wilcoxon signed-rank test, a non-parametric test was deemed suitable for paired data and used to compare the volumetric bone resorption rate between the test (HPCTM + allograft) and control (allograft only) groups. As for the soft tissue shrinkage, paired t-test was applied to explore any statistical significance at day 10,21 and 30. Statistical significance was set at p < 0.05. All analyses were conducted using IBM SPSS Statistics 25.

Being tested
Placental Extract, Allograft
Keywords
Alveolar ridge, Connective tissue, Extracellular matrix, Placental extracts, Wound healing, Tooth extraction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Placental ExtractBiological

    Participants will receive allografts bone substitutes mixed with flowable human placental derived connective tissue matrix in one extraction socket immediately following tooth extraction.

  • AllograftProcedure or surgery

    Participants will receive allografts bone substitutes solely in one extraction socket immediately following tooth extraction.

Study groups in NCT06915675
Study groupRoleWhat they receive
Placenta treatment armActive comparatorParticipants will receive allografts bone substitutes mixed with flowable human placental based connective tissue matrix in one extraction socket immediately following tooth extraction.
Receives: Biological: Placental Extract
Control armSham comparatorParticipants will receive allografts bone substitutes solely in one extraction socket immediately following tooth extraction.
Receives: Procedure: Allograft

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Soft tisse shrinakge at different time points of the test and control groups

    Using a measurement software ( Medit design, Medit, Republic of Korea) the intra-oral scans (.STL files) obtained at different time points of the healing process will be super-imposed and aligned. the following region of interest will be selected:

    • Mesio-distally: 1,5 mm away from the concerned papilla peak.
    • Apically: A bucco-lingual/palatal line tangent to the visible muco-gingival line and parallel to the occlusal surface.

    The deviation between the different scans which corresponds the soft tissue shrinkage will be automatically calculated in millimeters as a mean value with standard deviation

    Measured: 30 days

  2. Bone resorption rate in test and control groups

    . A semi-automatic segmentation software (ITK-Snap 4.0, U.S. National Institute of Biomedical Imaging and BioEngineering, USA) was used to load and segment the pre and post CBCT scans. First, both CBCTs were oriented according to the Frankfort plane, then aligned using multiple fixe landmarks in different orientations to ensure a perfect match and an easy reproducibility. A standard region of interest was applied for all the measured sites as follow:

    A standard region of interest was applied for all the measured sites as follow:

    • Mesio-distal limit: 1.5 mm away from the mesial and distal surface of adjacent tooth.
    • Bucco-lingual limit: limited to the observed bone dimensions.
    • Apico-coronal limit: Coronally the most detectable bone peak at the mesial and distal sides; apically, 1.5 mm below the root tip.

    Using pixel-based scale, a specific threshold value was used to select and separate the desired structure from its surroundings of both pre and post-surgery CBCT. Following the aut

    Measured: 4 months

Secondary outcomes (1)
  1. Clinical observation of the wound healing at control and test groups at 10, 21 and 30 days post-op

    Before the surgery, clinical photographs using a digital single-lens reflex camera (Canon 90D, 100mm macro lens, Tokyo, Japan) equipped with a light diffuser (Flashkap, USA) of each patient were collected and stored separately.

    After the surgery, the patients were asked to re-visit the dental clinic at 10,21 and 30 days post-operatively for a check-up, clinical photographs and intra-oral scans.

    Same angulation photographs were stacked and an independent oral surgeon described the observed change in the alveolar tissues.

    Measured: 30 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Apr 2025
  2. Study start23 Aug 2024
  3. Primary completion11 Feb 2025
  4. Study completion10 Apr 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
Following the inclusion and exclusion criteria, 10 patients presenting a split mouth design will be enrolled in the study where one dental extraction site will serve as a test and the other will be the control
Masking
Single blind
Who is masked
Investigator
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06915675
Sponsor's protocol ID
USJ-2024-175
Status last verified
Apr 2025
First submitted
28 Mar 2025
Last updated
11 Apr 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Gulameabasse S, Gindraux F, Catros S, Fricain JC, Fenelon M. Chorion and amnion/chorion membranes in oral and periodontal surgery: A systematic review. J Biomed Mater Res B Appl Biomater. 2021 Aug;109(8):1216-1229. doi: 10.1002/jbm.b.34783. Epub 2020 Dec 22.

    PubMed 33354857
  • Kalsi AS, Kalsi JS, Bassi S. Alveolar ridge preservation: why, when and how. Br Dent J. 2019 Aug;227(4):264-274. doi: 10.1038/s41415-019-0647-2.

    PubMed 31444438
  • Chappuis V, Araujo MG, Buser D. Clinical relevance of dimensional bone and soft tissue alterations post-extraction in esthetic sites. Periodontol 2000. 2017 Feb;73(1):73-83. doi: 10.1111/prd.12167.

    PubMed 28000281
  • Chappuis V, Engel O, Reyes M, Shahim K, Nolte LP, Buser D. Ridge alterations post-extraction in the esthetic zone: a 3D analysis with CBCT. J Dent Res. 2013 Dec;92(12 Suppl):195S-201S. doi: 10.1177/0022034513506713. Epub 2013 Oct 24.

    PubMed 24158340

Questions about this trial

What is this clinical trial studying?

A study testing Placental Extract and Allograft in people with Dental Extraction, run by Saint-Joseph University at 1 site in Lebanon.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 11 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Lebanon. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Soft tisse shrinakge at different time points of the test and control groups (time frame: 30 days). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06915675, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Apr 2025; AzTrials last refreshed its copy on 27 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in